跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
VYVANSE CAPSULES 40 mg
Approved
STANDARD
VYVANSE CAPSULES 40 mg
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
10f2c19f8a0c30fd
Company
Unknown
Type
Standard
Approval Details
Approval Id
10f2c19f8a0c30fd
Drug Name
VYVANSE CAPSULES 40 mg
Active Ingredients
Lisdexamfetamine Dimesylate
40.0 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
10f2c19f8a0c30fd
Type
Standard
Back to HSA Approvals
VYVANSE CAPSULES 40 mg - HSA Drug Approval Details